Market Size of Bovine Mastitis Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 1.60 Billion |
Market Size (2029) | USD 2.04 Billion |
CAGR (2024 - 2029) | 4.88 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Bovine Mastitis Market Analysis
The Bovine Mastitis Market size is estimated at USD 1.60 billion in 2024, and is expected to reach USD 2.04 billion by 2029, growing at a CAGR of 4.88% during the forecast period (2024-2029).
The COVID-19 pandemic had an unprecedented impact on the growth of the bovine mastitis market. In 2020, it significantly impacted the supply chain of products for the treatment of bovine mastitis. Containment measures, such as lockdowns and social distancing, created problems in terms of the availability of medicines due to reduced operations in veterinary pharmacies. However, the relaxation of strict regulations post the pandemic led to the normal functioning of supply chain, which contributed to the market's growth.
The major factors responsible for the growth of the bovine mastitis market include the rising incidences of disease, the increasing product launches for animal healthcare, and technological advancements in the field of drug discovery and development.
Bovine mastitis is one of the major concerns in the dairy industry worldwide. Dairy farmers are facing huge economic losses with the rising incidences of cattle death globally. For instance, as per the data published by the MSD Manual in October 2022, severe mastitis caused by coliforms results in an higher incidence of cow death (30-50%) worldwide. These mortality rates in cows increase the direct and indirect costs, such as diagnostics, milk loss, veterinary services, labor, future milk production losses, and therapeutics. The rising bovine mastitis cases and related market loss are fuelling the demand for antibiotics in the treatment of the condition.
The increasing investments in the development of bovine mastitis treatment are expected to contribute to the market's growth. For instance, in August 2021, Stonehaven Incubates invested in the Anifera to conduct additional studies to explore the impact and effectiveness of adjunct therapy in bovine mastitis.
However, the rising threat of antibiotic resistance and a lack of awareness about the disease are expected to slow the market's growth over the forecast period.
Bovine Mastitis Industry Segmentation
As per the scope of the report, bovine mastitis is an inflammatory disease of the udder tissue in the mammary gland caused due to physical trauma or microorganism infections. It is considered the most common disease leading to economic loss in dairy industries due to reduced yield and poor quality of milk.
The bovine mastitis market is projected to register a CAGR of 5.1% during the forecast period. the bovine mastitis market is segmented by type (clinical and sub-clinical), product (antibiotics, surgery, vaccines, pain killers, and other products), route of administration (intra-mammary and systemic), therapy (lactating period and dry period), end user (hospitals, veterinary centers, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally.
By Type | |
Clinical Mastitis | |
Sub-clinical Mastitis |
By Product | |
Antibiotics | |
Surgery | |
Vaccines | |
Pain Killers | |
Other Products |
By Route of Administration | |
Intra-mammary | |
Systemic |
By Therapy | |
Lactating Period | |
Dry Period |
By End User | |
Hospitals and Clinics | |
Veterinary Centers | |
Other End Users |
By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Bovine Mastitis Market Size Summary
The bovine mastitis market is experiencing a steady growth trajectory, driven by several key factors. The increasing incidence of bovine mastitis, a significant concern in the dairy industry, is prompting a rise in demand for effective treatment solutions. This demand is further fueled by technological advancements in drug discovery and development, alongside a surge in product launches aimed at enhancing animal healthcare. The market's expansion is also supported by investments in research and development, as seen in initiatives like those by Stonehaven Incubates and the Institute of Global Food Security, which focus on exploring new treatment methodologies and reducing antibiotic reliance. Despite these positive trends, challenges such as antibiotic resistance and limited awareness about the disease pose potential hurdles to market growth.
Regionally, Asia-Pacific is anticipated to maintain a substantial share of the bovine mastitis market, attributed to the high prevalence of the disease and the adoption of advanced treatment technologies. Collaborative efforts in the region, such as those involving Dairy Australia and various universities, aim to improve dairy cow health and management while minimizing antibiotic use. The market is moderately competitive, with major players like Zoetis, Merck & Co. Inc, and Boehringer Ingelheim leading the charge. Innovations such as the PortaReader device, which detects subclinical mastitis on-site, exemplify the ongoing advancements within the industry. These developments, coupled with strategic investments, are expected to sustain the market's growth momentum over the forecast period.
Bovine Mastitis Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Incidence of the Disease
-
1.2.2 Increasing Product Launches for Animal Healthcare
-
1.2.3 Technological Advancements in the Field of Drug Discovery and Development
-
-
1.3 Market Restraints
-
1.3.1 Rising Threat of Antibiotic Resistance
-
1.3.2 Lack of Awareness About the Disease
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Type
-
2.1.1 Clinical Mastitis
-
2.1.2 Sub-clinical Mastitis
-
-
2.2 By Product
-
2.2.1 Antibiotics
-
2.2.2 Surgery
-
2.2.3 Vaccines
-
2.2.4 Pain Killers
-
2.2.5 Other Products
-
-
2.3 By Route of Administration
-
2.3.1 Intra-mammary
-
2.3.2 Systemic
-
-
2.4 By Therapy
-
2.4.1 Lactating Period
-
2.4.2 Dry Period
-
-
2.5 By End User
-
2.5.1 Hospitals and Clinics
-
2.5.2 Veterinary Centers
-
2.5.3 Other End Users
-
-
2.6 By Geography
-
2.6.1 North America
-
2.6.1.1 United States
-
2.6.1.2 Canada
-
2.6.1.3 Mexico
-
-
2.6.2 Europe
-
2.6.2.1 Germany
-
2.6.2.2 United Kingdom
-
2.6.2.3 France
-
2.6.2.4 Italy
-
2.6.2.5 Spain
-
2.6.2.6 Rest of Europe
-
-
2.6.3 Asia-Pacific
-
2.6.3.1 China
-
2.6.3.2 Japan
-
2.6.3.3 India
-
2.6.3.4 Australia
-
2.6.3.5 South Korea
-
2.6.3.6 Rest of Asia-Pacific
-
-
2.6.4 Middle East and Africa
-
2.6.4.1 GCC
-
2.6.4.2 South Africa
-
2.6.4.3 Rest of Middle East and Africa
-
-
2.6.5 South America
-
2.6.5.1 Brazil
-
2.6.5.2 Argentina
-
2.6.5.3 Rest of South America
-
-
-
Bovine Mastitis Market Size FAQs
How big is the Bovine Mastitis Market?
The Bovine Mastitis Market size is expected to reach USD 1.60 billion in 2024 and grow at a CAGR of 4.88% to reach USD 2.04 billion by 2029.
What is the current Bovine Mastitis Market size?
In 2024, the Bovine Mastitis Market size is expected to reach USD 1.60 billion.